News AstraZeneca PLC NYSE

Stocks

AZN

US0463531089

Pharmaceuticals

Market Closed - NYSE 16:00:02 2026-09-23 EDT			Pre-market 07:09:46
163.33 ^USD	-2.99%		163.76	+0.26%

12:55am	Nordic stocks in North America, Astra Zeneca fell 1.2%	FW
09-23	Polaris Rx And AstraZeneca Name Polaris Rx Exclusive U.S. Distributor Of AstraZeneca's FluMist® Home Service For Second Consecutive Year	CI

All News

Mentions Relevance

02:10am	AstraZeneca : Alexion advances pioneering leadership in gMG care with data at 2026 AANEM Annual Meeting and MGFA Scientific Session	PU
09-23	Polaris Rx And AstraZeneca Name Polaris Rx Exclusive U.S. Distributor Of AstraZeneca's FluMist® Home Service For Second Consecutive Year	CI
09-23	AstraZeneca's Asthma Maintenance Treatment Gets EU Approval	MT
09-23	AstraZeneca celebrates EU approval of Trixeo for treating asthma	AN
09-23	AstraZeneca PLC Receives EU Approval For Trixeo Aerosphere For The Maintenance Treatment Of Asthma	CI
09-23	AstraZeneca, Unicef Kick Start New Phase of Young Health Program	MT
09-23	AstraZeneca's Trixeo Aerosphere Wins EU Approval for Asthma Treatment	MT
09-21	AstraZeneca And Daiichi Sankyo Receive CHMP Recommendation For Enhertu As Adjuvant Treatment For HER2-Positive Early Breast Cancer In The EU	CI
09-21	University of Dundee: Tayside team recruit first global participant in clinical trial for Chronic Kidney Disease	AQ
09-21	Two favorable EU opinions for AstraZeneca
09-21	AstraZeneca PLC Klygefa Recommends For EU Approval By CHMP	CI
09-21	Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs	RE
09-18	Alexion Biologics License Application for Efzimfotase Alfa Accepted and Granted Priority Review by Us Fda for Treatment of Patients with Hypophosphatasia Aged 2 Years and Older	CI
09-18	AstraZeneca drug Klygefa gains positive opinion from EU's CHMP	AN
09-18	AstraZeneca's Alexion Gets Positive EU Recommendation for Klygefa in Rare Muscle Disease	MT
09-18	EU Medicines Agency Panel Backs Indication Extension for AstraZeneca, Daiichi Sankyo's Breast Cancer Drug	MT
09-18	AstraZeneca : Klygefa (gefurulimab) recommended for approval in the EU by CHMP for the treatment of adults with generalised myasthenia gravis (gMG)	PU
09-18	AstraZeneca, Daiichi celebrate another recommended approval of Enhertu	AN
09-18	AstraZeneca, Daiichi Sankyo's Enhertu Recommended for EU Approval for HER2 Positive Breast Cancer	MT
09-18	AstraZeneca's Alexion Wins European Medicines Agency Panel's Positive Opinion for Autoimmune Disease Drug	MT
09-18	AstraZeneca chief executive buys GBP7 million in shares	AN
09-18	Big Picture Bio Founded to Identify, Design and Optimise Promising Cancer Combination Therapies	AQ
09-18	Onco360(R) Has Been Selected as a National Pharmacy Partner for ETCAMAH (camizestrant)	AQ
09-18	FDA Grants Priority Review to AstraZeneca's Efzimfotase
09-18	AstraZeneca Wins FDA Priority Review for Rare Bone Disease Drug	MT